Phenazine

Phenazine

SCHEMBL2291612

CCOCC.c1ccc2nc3ccccc3nc2c1

nearest known ligand 0.58

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.58
NQO2 P16083 7/20 0.48
KDM4E B2RXH2 6/20 0.45
ALDH1A1 P00352 4/20 0.45
POLB P06746 4/20 0.45
NPC1 O15118 3/20 0.45
HPGD P15428 3/20 0.45
MEN1 O00255 2/20 0.45
KMT2A Q03164 2/20 0.45
GAA P10253 2/20 0.45
LMNA P02545 1/20 0.45
RAB9A P51151 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
USP2 O75604 1/20 0.42
CACNA1B Q00975 1/20 0.42
APBA1 Q02410 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
NCF1 P14598 1/20 0.42
GLA P06280 2/20 0.42
ACHE P22303 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acridine SCHEMBL5192718 0.86 ALDH1A1 (0.65) MAPTNQO2KDM4EALDH1A1POLB
Naphthalene SCHEMBL1829374 0.80 CYP2A6 (0.50) KDM4EALDH1A1HPGDGAALMNA
Quinoxaline SCHEMBL1259050 0.80 ALDH1A1 (0.41) MAPTKDM4EALDH1A1POLBNPC1
Ether SCHEMBL16742369 0.80 ALDH1A1 (0.49) MAPTKDM4EALDH1A1NPC1HPGD
Quinoline SCHEMBL1257445 0.78 ALDH1A1 (0.68) MAPTKDM4EALDH1A1POLBNPC1
Naphthalene SCHEMBL8526780 0.78 CYP2A6 (0.47) KDM4EALDH1A1HPGDGAALMNA
Phenazine SCHEMBL28805065 0.78 MAPT (0.65) MAPTNQO2KDM4EALDH1A1POLB
Phenanthrene SCHEMBL27863132 0.77 ALDH1A1 (0.60) MAPTKDM4EALDH1A1HPGDLMNA
Phenazine SCHEMBL9049 0.76 MAPT (1.00) MAPTNQO2KDM4EALDH1A1POLB
Phenazine SCHEMBL29356959 0.76 MAPT (1.00) MAPTNQO2KDM4EALDH1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2265726-B1 BIOSENSOR WITH IMPROVED ANALYTE SPECIFICITY ROCHE DIAGNOSTICS GMBH (DE) 2014-05-07 EP disclosed
US-8535511-B2 Methods for electrochemical analysis using matrix compositions with alkylphenazine quaternary salt and a nitrosoaniline ROCHE DIAGNOSTICS OPERATIONS, INC. (US) 2013-09-17 US disclosed
US-8008037-B2 Matrix composition with alkylphenazine quaternary salt and a nitrosoaniline ROCHE DIAGNOSTICS OPERATIONS, INC. (US) 2011-08-30 US disclosed
EP-2265726-A1 BIOSENSOR WITH IMPROVED ANALYTE SPECIFICITY Roche Diagnostics GmbH (DE) 2010-12-29 EP disclosed
WO-2009118157-A1 BIOSENSOR WITH IMPROVED ANALYTE SPECIFICITY ROCHE DIAGNOSTICS GMBH (DE) 2009-10-01 WO disclosed
US-20090246808-A1 BIOSENSOR WITH IMPROVED ANALYTE SPECIFICITY ROCHE DIABETES CARE, INC. 2009-10-01 US disclosed